STUDY_ID,INCLUDE,X1,bibtype,abstract,author,isbn,journal,keywords,pages,title,url,volume,year,number,annote,doi,edition,language,pmid,ROUND1INC,ROUND1REV,ROUND2INC,ROUND2REV,REVIEWERS,FT_REV,DOWNLOADED
6453,MAYBE,Fitzgerald2012,Article,"Sepsis-induced purpura fulminans is a rare but life-threatening condition characterized by rapidly progressive hemorrhagic infarction of the skin due to dermal vascular thrombosis resulting in tissue loss and severe scarring. Although most commonly related to meningococcal or invasive group A streptococcal disease, it may also be caused by several other bacterial or viral pathogens including Pneumococcus and Varicella. Purpura fulminans associated with Staphylococcus aureus sepsis is rare but has been reported in adults. However, the syndrome is very unusual in children, and to our knowledge, only 2 cases of staphylococcal purpura fulminans have been reported in children, both due to methicillin-susceptible S aureus in the United Kingdom. We report the first well-described case of purpura fulminans due to community-associated methicillin-resistant S aureus in a child.",C J Fitzgerald and T V Pranikoff and G A Ross and S Mou and L B Givner and A K Shetty,0735-6757,Am J Emerg Med,"*Methicillin-Resistant Staphylococcus aureus,Anti-Bacterial Agents/administration {\&} dosage/ther,Child, Preschool,Clindamycin/administration {\&} dosage/therapeutic us,Drug Therapy, Combination,Emergency Service, Hospital,Humans,Male,Purpura Fulminans/*etiology/microbiology,Staphylococcal Infections/*complications/microbiol,Vancomycin/administration {\&} dosage/therapeutic use",1013.e1--4,{Purpura fulminans caused by community-associated methicillin-resistant Staphylococcus aureus},NA,30,2012,6,"1532-8171
Fitzgerald, Casimir J
Pranikoff, Thomas V
Ross, Gregory A
Mou, Steven
Givner, Laurence B
Shetty, Avinash K
Case Reports
Journal Article
United States
Am J Emerg Med. 2012 Jul;30(6):1013.e1-4. doi: 10.1016/j.ajem.2011.03.032. Epub 2011 Jun 8.",10.1016/j.ajem.2011.03.032,2011-06-07,eng,21641144,YES,Cale,NO,Brooke,Allison,Zach_1,
3068,YES,Cao2012a,Article,"Introduction: Bacterial infections of the intra-abdominal require immediate, invariably empiric antibiotic therapy. Thus, antibacterial susceptibility data among intra-abdominal infection pathogens is important to define current prevalence of resistance. Methods: During 2009-2011, a total of 902 organisms derived from intra-abdominal sources, were isolated and susceptibility tested using Kirby-Bauer (KB) method, and tested for susceptibility to antibiotics according to the Clinical Laboratory Standards Institute (CLSI) guidelines. Results: Of the 902 clinical isolates, gramnegative bacilli and gram-positive cocci accounted for 83.6{\%} and 16.4{\%} respectively. Escherichia coli was the species isolated most commonly (41.4{\%}), and 8.6{\%} of these were extended-spectrum $\beta$-lactamase (ESBL)- positive. The other common pathogens were Klebsiella pneumonia (12.3{\%}), pseudomonas aeruginosa (11.8{\%}), acinetobacter baumannii (10.3{\%}) and staphylococci (6.9{\%}). ESBLs-producing strains accounted for 56.2{\%} and 52.5{\%} of escherichia coli and klebsiella spp. respectively. Methicillin-resistant staphylococcus aureus (MRSA) accounted for 44.7{\%} and methicillin-resistant coagulase negative staphylococci accounted for 38.2{\%} in staphylococcus aureus and coagulase negative staphylococci. Overall, Carbapenems were the antibiotic most active against enterobacteriaceae for which it has breakpoints ({\textgreater}96.6{\%}) followed by amikacin (91.0{\%}), and piperacillin-tazobactam (89.3{\%}), whereas rates of resistance to ceftriaxone, cefotaxime, ciprofloxacin, and levofloxacin were documented to be 29.7{\%}, 23.6{\%}, 21.5{\%}, and 20.1{\%}, respectively. Vancomycin was the most potent antimicrobial against gram positive cocci. Amphotericin B was the most active antibiotic against fungi. No vancomycin-intermediate Staphylococcus. aureus (VISA) or Vancomycinresistant Staphylococcus aureus (VRSA) isolate was found. Conclusions: This study documented substantial resistance to standard antimicrobial therapy among bacterial commonly isolated from intraabdominal infection in Northeast China. Longitudinal surveillance of susceptibility patterns is useful to guide recommendations for empiric antibiotic use in intra-abdominal infections.",X Cao and J Jiang and L Ma and R M Liu and Q Wang and J Suo,0815-9319,Journal of Gastroenterology and Hepatology,"Acinetobacter baumannii,Asian,Bacilli,China,Enterobacteriaceae,Escherichia coli,Gram positive cocci,Klebsiella,Klebsiella pneumoniae,Pseudomonas aeruginosa,Staphylococcus,Staphylococcus aureus,abdominal infection,amikacin,amphotericin B,antibiotic agent,antibiotic sensitivity,antibiotic therapy,antiinfective agent,antimicrobial therapy,bacterial infection,bacterium,carbapenem derivative,cefotaxime,ceftriaxone,ciprofloxacin,clinical laboratory,coagulase negative Staphylococcus,fungus,human,levofloxacin,methicillin resistant Staphylococcus aureus,meticillin,pathogenesis,patient,penicillinase,piperacillin,prevalence,species,tazobactam,vancomycin",60,{Antimicrobial susceptibility of bacteria isolated from patients with intra-abdominal infections in China},http://www.embase.com/search/results?subaction=viewrecord{\&}from=export{\&}id=L70952036 http://dx.doi.org/10.1111/jgh.12006 http://rd8hp6du2b.search.serialssolutions.com?sid=EMBASE{\&}issn=08159319{\&}id=doi:10.1111{\%}2Fjgh.12006{\&}atitle=Antimicrobial+susceptibility+of,27,2012,NA,NA,NA,NA,NA,NA,YES,Allison,YES,Nchedo,Nchedo,Zach_1,
15971,MAYBE,Paramo-Rivas2015,Article,"Background: Urinary tract infection (UTI) is the third leading cause of morbidity from infections, diagnosis and appropriate treatment involves the determination of the pathogen and antimicrobial sensitivity or resistance. The empirical treatment of patients with extended spectrum beta lactamase (ESBL) bacteria lead the progression of the disease by an ineffective treatment. objective: To identify the frequency of pathogens and antimicrobial resistance patterns of microorganisms isolated from patients with community-acquired urinary tract infection, hospitalized at Internal Medicine Service of Nuevo Sanatorio Durango, Mexico City. Material and method: A prospective, observational, single-center cross-sectional descriptive study was conducted. They were selected hospitalized patients with UTI in the internal medicine service of Nuevo Sanatorio Durango, Mexico City. Microorganisms were isolated from the urine of patients by culture, strains were typed by biochemical tests and susceptibility testing and resistance were performed. results: In patients with urinary symptoms (n=78) urine culture was performed and in 46, bacterial isolates were obtained. Escherichia coli was identified in 91.5{\%} and within this group 38.3{\%} showed positive ESBL features. The greatest resistance was against ampicillin-sulbactam, ciprofloxacin, ceftriaxone and TMP/SMZ. Conclusions: This study demonstrated the high incidence of beta-lactamase-producing organisms in UTI patients hospitalized in the internal medicine at New Hospital in Durango, Mexico. This study will improve clinical guide empirical therapy in patients with urinary tract infections.",F P치ramo-Rivas and A Tovar-Serrano and M E Rend칩n-Mac\'{i}as,0186-4866,Medicina Interna de Mexico,"Escherichia coli,Mexico,antibiotic resistance,article,ceftriaxone,ciprofloxacin,cross-sectional study,extended spectrum beta lactamase,hospital patient,hospitalization,human,internal medicine,nonhuman,observational study,prospective study,sultamicillin,urinary tract infection,urine culture",34--40,"{Antimicrobial resistance in patients with urinary tract infection hospitalized at Internal Medicine Service of nuevo Sanatorio durango, from January to December 2013}",http://www.embase.com/search/results?subaction=viewrecord{\&}from=export{\&}id=L605465010 http://rd8hp6du2b.search.serialssolutions.com?sid=EMBASE{\&}issn=01864866{\&}id=doi:{\&}atitle=Antimicrobial+resistance+in+patients+with+urinary+tract+infection+hospitalized+at+Int,31,2015,1,NA,NA,NA,NA,NA,MAYBE,Jake,NO,Mushtaq,Allison,Zach_1,
19152,YES,Shin2012,Article,"We report a multidrug-resistant strain of Leclercia adecarboxylata responsible for catheter-related bacteremia in a 47-year-old female with breast cancer. The isolated strain was resistant to several beta-lactams, aminoglycosides, and folate pathway inhibitors and harbored bla(TEM-1) and bla(CTX-M) group 1 and intl1 genes (dfrA12-orfF-aadA2) as genetic determinants for resistance. Based on a review of the L. adecarboxylata literature, there have been only 4 reports of antibiotic-resistant strains. To our knowledge, this is the first report of an L. adecarboxylata strain with simultaneous resistance to beta-lactams, aminoglycosides, and sulfonamides.",G W Shin and M J You and H S Lee and C S Lee,0095-1137,J Clin Microbiol,",16S/genetics,Anti-Bacterial Agents/pharmacology,Bacteremia/*diagnosis/microbiology/pathology,Bacterial,Bacterial/chemistry/genetics,Breast Neoplasms/*complications,Catheter-Related Infections/*diagnosis/microbiolog,DNA,Drug Resistance,Enterobacteriaceae Infections/*diagnosis/microbiol,Enterobacteriaceae/classification/genetics/*isolat,Female,Genes,Genotype,Gram positive bacterium,Humans,Microbial Sensitivity Tests,Middle Aged,Molecular Sequence Data,Multiple,RNA,RNA 16S,Ribosomal,Ribosomal/chemistry/genetics,Sequence Analysis,adult,amikacin,aminoglycoside antibiotic agent,amoxicillin plus clavulanic acid,ampicillin,amplicon,antibiotic resistance,antibiotic sensitivity,article,aztreonam,bacterium isolation,beta lactam antibiotic,beta-Lactamases/genetics,bla CTX M gene,bla TEM 1 gene,breast cancer,carbapenem derivative,case report,catheter infection,catheter related bacteremia,cefaclor,cefalotin,cefepime,cefixime,cefminox,cefoperazone,cefotaxime,cefoxitin,ceftazidime,cephalosporin derivative,cotrimoxazole,disease association,female,fever,folic acid derivative,gene,genetic identification,genomic DNA,gentamicin,human,imipenem,intl1 gene,isepamicin,leclercia adecarboxylata,leukocyte count,meropenem,myalgia,nucleotide sequence,pathogenesis,peripherally inserted central venous catheter,piperacillin,piperacillin plus tazobactam,polymerase chain reaction,priority journal,quinoline derived antiinfective agent,sulfonamide,treatment response,unindexed drug",3129--3132,{Catheter-related bacteremia caused by multidrug-resistant Leclercia adecarboxylata in a patient with breast cancer},http://www.embase.com/search/results?subaction=viewrecord{\&}from=export{\&}id=L365469456 http://dx.doi.org/10.1128/JCM.00948-12 http://rd8hp6du2b.search.serialssolutions.com?sid=EMBASE{\&}issn=00951137{\&}id=doi:10.1128{\%}2FJCM.00948-12{\&}atitle=Catheter-related+bactere,50,2012,9,"From Duplicate 1 (Catheter-related bacteremia caused by multidrug-resistant Leclercia adecarboxylata in a patient with breast cancer - Shin, G W; You, M J; Lee, H S; Lee, C S)

1098-660x
Shin, Gee-Wook
You, Myung-Jo
Lee, Hye-Soo
Lee, Chang-Seop
Case Reports
Journal Article
United States
J Clin Microbiol. 2012 Sep;50(9):3129-32. doi: 10.1128/JCM.00948-12. Epub 2012 Jul 3.",10.1128/jcm.00948-12,2012-07-05,eng,22760051,NO,Erica,YES,Zach,Brooke,Zach_1,
15999,YES,Park2007b,Article,"Mycobacterium xenopi is a nontuberculous mycobacterium (NTM) that rarely causes pulmonary disease in Asia. Here we describe the first case of M. xenopi pulmonary disease in Korea. A 66-year-old man was admitted to our hospital with a 2-month history of productive cough and hemoptysis. His past medical history included pulmonary tuberculosis 44 years earlier, leading to a right upper lobectomy Chest X-ray upon admission revealed cavitary consolidation involving the entire right lung. Numerous acid-fast bacilli were seen in his initial sputum, and M. xenopi was subsequently identified in more than five sputum cultures, using molecular methods. Despite treatment with clarithromycin, rifampicin, ethambutol, and streptomycin, the infiltrative shadow revealed on chest X-ray increased in size. The patient's condition worsened, and a right completion pneumonectomy was performed. The patient consequently died of respiratory failure on postoperative day 47, secondary to the development of a late bronchopleural fistula. This case serves as a reminder to clinicians that the incidence of NTM infection is increasing in Korea and that unusual NTM are capable of causing disease in non-immunocompromised patients.",H Y Park and W J Koh and O J Kwon and N Y Lee and Y M Shim and Y K Park and G H Bai and H S Mun and B J Kim,0513-5796,Yonsei Medical Journal,"Korea,Mycobacterium xenopei,acid fast bacterium,aged,amikacin,antibiotic sensitivity,article,atypical mycobacteriosis,bacterium identification,case report,clarithromycin,coughing,drug substitution,drug withdrawal,ethambutol,fatality,general condition deterioration,hearing,hemoptysis,human,isoniazid,kanamycin,lung cavitation,lung infection,lung infiltrate,lung lobectomy,lung resection,lung tuberculosis,male,moxifloxacin,respiratory failure,rifampicin,side effect,sputum culture,streptomycin,thorax radiography",871--875,{Pulmonary disease caused by Mycobacterium xenopi: The first case in Korea},http://www.embase.com/search/results?subaction=viewrecord{\&}from=export{\&}id=L350130481 http://dx.doi.org/10.3349/ymj.2007.48.5.871 http://rd8hp6du2b.search.serialssolutions.com?sid=EMBASE{\&}issn=05135796{\&}id=doi:10.3349{\%}2Fymj.2007.48.5.871{\&}atitle=Pulmonary+dise,48,2007,5,NA,NA,NA,NA,NA,YES,Brooke,YES,Ayomide,Ayomide,Zach_1,
15654,YES,Otte2017,Article,We here present the first case of a metronidazole resistant nimD positive Bacteroides stercoris. The isolate originated from a polymicrobial intra-abdominal abscess in a 70-year-old woman. The nimD gene was detected by use of whole-genome shotgun sequencing and the subsequent use of the ResFinder 2.1 web service.,E Otte and H L Nielsen and H Hasman and D Fuglsang-Damgaard,"1095-8274
1075-9964",Anaerobe,"Bacteroides,Bacteroides stercoris,C reactive protein,Danish citizen,abdominal abscess,abscess drainage,aged,antibiotic resistance,bacterial growth,bacterium isolate,case report,cefuroxime,ciprofloxacin,drug substitution,drug withdrawal,female,fever,follow up,gene,human,human cell,letter,lower abdominal pain,metronidazole,minimum inhibitory concentration,nimD gene,nonhuman,pelvis abscess,priority journal,tachycardia,vancomycin,x-ray computed tomography",91--93,"{First report of metronidazole resistant, nimD-positive, Bacteroides stercoris isolated from an abdominal abscess in a 70-year-old woman}",http://www.embase.com/search/results?subaction=viewrecord{\&}from=export{\&}id=L613825528 http://dx.doi.org/10.1016/j.anaerobe.2016.12.010 http://rd8hp6du2b.search.serialssolutions.com?sid=EMBASE{\&}issn=10958274{\&}id=doi:10.1016{\%}2Fj.anaerobe.2016.12.010{\&}atitle=Firs,43,2017,NA,NA,NA,NA,NA,NA,YES,Erica,NO,Mushtaq,Zach,Zach_1,
869,YES,Antoniadou2007,Article,"OBJECTIVES: Infections due to multidrug-resistant (MDR) Gram-negative pathogens in the ICU have prompted the use of colistin, an antibiotic forgotten for decades. The aim of this retrospective observational study was to record and present the emergence of colistin-resistant Klebsiella pneumoniae (CRKB) in a Greek ICU. METHODS: In a new university tertiary hospital, the first patients admitted in the ICU were already colonized or infected with MDR pathogens, and this led to frequent colistin use as part of empirical or microbiologically documented therapy. Colistin resistance was defined as MIC {\textgreater}4 mg/L by the Etest method. All CRKB isolated in surveillance cultures or clinical specimens in the ICU during the period 2004-5 were recorded along with patients' characteristics. RESULTS: Eighteen CRKB were isolated from 13 patients over a 16 month period, representing either colonizing or infective isolates. Patients' mean age was 70 years, with a mean APACHE II score at admission of 22. They all had a long hospitalization (median 69 days) and a long administration of colistin (median 27 days). Colistin-resistant isolates were implicated as pathogens in two bacteraemias, a ventilator-associated pneumonia and two soft tissue infections. Repetitive extragenic palindromic PCR identified six distinct clones, and horizontal transmission was also documented. CONCLUSIONS: Selective pressure due to extensive or inadequate colistin use may lead to the emergence of colistin resistance among K. pneumoniae isolates, jeopardizing treatment options in the ICU, potentially increasing morbidity and mortality of critically ill patients and necessitating prudent use of colistin.",A Antoniadou and F Kontopidou and G Poulakou and E Koratzanis and I Galani and E Papadomichelakis and P Kopterides and M Souli and A Armaganidis and H Giamarellou,"0305-7453
1460-2091",Journal of Antimicrobial Chemotherapy,",*Intensive Care Units,APACHE,Acinetobacter baumannii,Aged,Anti-Bacterial Agents/*pharmacology,Apache,Bacteremia/microbiology,Bacterial/*genetics,Colistin/*pharmacology,Drug Resistance,Drug Utilization,Etest,Female,Genes,Greece,Humans,Klebsiella Infections/*microbiology,Klebsiella pneumoniae,Klebsiella pneumoniae/*drug effects/*genetics,Male,Multigene Family/*genetics,Pseudomonas aeruginosa,Reverse Transcriptase Polymerase Chain Reaction,aged,analytic method,animal cell,antibiotic resistance,article,bacteremia,bacterial colonization,bacterial infection,bacterium culture,bacterium isolate,bacterium isolation,clinical article,colistin,controlled study,critically ill patient,disease transmission,drug use,hospital admission,human,imipenem,intensive care unit,length of stay,medical decision making,minimum inhibitory concentration,morbidity,mortality,multidrug resistance,nonhuman,observational study,polymerase chain reaction,soft tissue infection,tetracycline,tigecycline,treatment duration,university hospital,ventilator associated pneumonia",786--790,{Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster},http://www.embase.com/search/results?subaction=viewrecord{\&}from=export{\&}id=L47073420 http://dx.doi.org/10.1093/jac/dkl562 http://rd8hp6du2b.search.serialssolutions.com?sid=EMBASE{\&}issn=03057453{\&}id=doi:10.1093{\%}2Fjac{\%}2Fdkl562{\&}atitle=Colistin-resistant+isolates,59,2007,4,"From Duplicate 2 (Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster - Antoniadou, A; Kontopidou, F; Poulakou, G; Koratzanis, E; Galani, I; Papadomichelakis, E; Kopterides, P; Souli, M; Armaganidis, A; Giamarellou, H)

Antoniadou, Anastasia
Kontopidou, Flora
Poulakou, Garifalia
Koratzanis, Evangelos
Galani, Irene
Papadomichelakis, Evangelos
Kopterides, Petros
Souli, Maria
Armaganidis, Apostolos
Giamarellou, Helen
Journal Article
England
J Antimicrob Chemother. 2007 Apr;59(4):786-90. Epub 2007 Feb 16.",10.1093/jac/dkl562,2007-02-20,eng,17307769,YES,Allison,YES,Nchedo,Nchedo,Zach_1,
22199,YES,Wang2014m,Article,NA,X Wang and H Li and C Zhao and H Chen and J Liu and Z Wang and Q Wang and Y Zhang and W He and F Zhang and H Wang,"1872-7913
0924-8579",Int J Antimicrob Agents,",Anti-Bacterial Agents/pharmacology,Child,China,Escherichia coli,Gene Expression,Humans,Kinetics,Klebsiella Infections/complications/*drug therapy/,Klebsiella pneumoniae,Klebsiella pneumoniae/drug effects/*enzymology/gen,Microbial Sensitivity Tests,Multilocus Sequence Typing,New Delhi metallo beta lactamase 9,Plasmids/*metabolism,Precursor Cell Lymphoblastic Leukemia-Lymphoma/com,acute lymphoblastic leukemia,amikacin,antibiotic resistance,antibiotic sensitivity,antimicrobial activity,aztreonam,bacterial gene,bacterial strain,bacterium examination,bacterium isolate,bacterium isolation,beta lactam antibiotic,beta-Lactam Resistance/*genetics,beta-Lactamases/genetics/*metabolism,beta-Lactams/pharmacology,broth dilution,case report,cefepime,cefotaxime,cefoxitin,ceftazidime,child,diarrhea,enzyme kinetics,fever,gene sequence,gentamicin,horizontal gene transfer,human,imipenem,infection,letter,levofloxacin,male,meropenem,metallo beta lactamase,minimum inhibitory concentration,multilocus sequence typing,new delhi metallo beta lactamase 1,nitrocefin,nonhuman,nucleotide sequence,perianal abscess,plasmid,polymyxin B,priority journal,sequence homology,tigecycline,unclassified drug,urine culture,vancomycin",90--91,{Novel NDM-9 metallo-$\beta$-lactamase identified from a ST107 Klebsiella pneumoniae strain isolated in China},http://www.embase.com/search/results?subaction=viewrecord{\&}from=export{\&}id=L53179463 http://dx.doi.org/10.1016/j.ijantimicag.2014.04.010 http://rd8hp6du2b.search.serialssolutions.com?sid=EMBASE{\&}issn=18727913{\&}id=doi:10.1016{\%}2Fj.ijantimicag.2014.04.010{\&}atitle,44,2014,1,"From Duplicate 2 (Novel NDM-9 metallo-beta-lactamase identified from a ST107 Klebsiella pneumoniae strain isolated in China - Wang, X; Li, H; Zhao, C; Chen, H; Liu, J; Wang, Z; Wang, Q; Zhang, Y; He, W; Zhang, F; Wang, H)

1872-7913
Wang, Xiaojuan
Li, Henan
Zhao, Chunjiang
Chen, Hongbin
Liu, Jingbo
Wang, Zhanwei
Wang, Qi
Zhang, Yawei
He, Wenqiang
Zhang, Feifei
Wang, Hui
Case Reports
Letter
Research Support, Non-U.S. Gov't
Netherlands
Int J Antimicrob Agents. 2014 Jul;44(1):90-1. doi: 10.1016/j.ijantimicag.2014.04.010. Epub 2014 May 21.",10.1016/j.ijantimicag.2014.04.010,2014-06-11,eng,24913967,MAYBE,Jake,YES,Erica,Erica,Zach_1,
7328,MAYBE,Giordano2016,Article,"Wautersiella falsenii is a Gram-negative, non-motile rod, which grows aerobically on common isolation media and is the only acknowledged species among the genus Wautersiella. Two genomovars, namely 1 and 2, phenotypically indistinguishable but genotypically different, are described. To date, few case reports detailing the clinical disease associated with W. falsenii have been reported, all describing localized infection. To our knowledge, this study reports the first isolation of W. falsenii genomovar 2 from a respiratory sample of an immunosuppressed man. Our hypothesis is that the patient was harboring W. falsenii genomovar 2 and both the immunosuppression and the antimicrobial treatments provided a chance for this organism to emerge. The clinical significance of this result is yet to be evaluated. Although infection with W. falsenii remains rare, this bacterium should not be underestimated mainly because of its natural resistance to many available antimicrobials.",C Giordano and M Falleni and A L Capria and F Caracciolo and M Petrini and S Barnini,2214-2509,IDCases,"Candida antigen,Gram negative bacterium,Klebsiella pneumoniae,RNA 16S,Wautersiella falsenii,aciclovir,adult,amphotericin B lipid complex,antibiotic sensitivity,article,bacterial strain,bacterium identification,bacterium isolation,blood transfusion,bone marrow transplantation,cancer chemotherapy,case report,cefotaxime,ceftazidime,central venous catheter,ciprofloxacin,clarithromycin,colistin,coughing,cytarabine,daptomycin,doripenem,drug megadose,ertapenem,erythropoietin,fever,filgrastim,fluconazole,fosfomycin,gene sequence,gentamicin,hemoglobin,human,imipenem,immune deficiency,leukocyte count,levofloxacin,male,matrix assisted laser desorption ionization time o,meropenem,minimum inhibitory concentration,mitoxantrone,nitrofurantoin,nucleotide sequence,phylogenetic tree,piperacillin plus tazobactam,priority journal,recurrent disease,respiratory system,sultamicillin,swelling,teicoplanin,thrombocyte count,tigecycline",27--29,{First report of Wautersiella falsenii genomovar 2 isolated from the respiratory tract of an immunosuppressed man},http://www.embase.com/search/results?subaction=viewrecord{\&}from=export{\&}id=L609034403 http://dx.doi.org/10.1016/j.idcr.2016.02.009 http://rd8hp6du2b.search.serialssolutions.com?sid=EMBASE{\&}issn=22142509{\&}id=doi:10.1016{\%}2Fj.idcr.2016.02.009{\&}atitle=First+report,4,2016,NA,NA,NA,NA,NA,NA,MAYBE,Brooke,NO,Mushtaq,Zach,Zach_1,
13557,YES,McElvaniaTeKippe2014,Article,"The objective of this study was to investigate the observation of daptomycin resistance in Corynebacterium striatum, both in vivo and in vitro. We describe a case of C. striatum bacteremia in a patient with a left ventricular assist device (LVAD); the initial isolate recovered was daptomycin susceptible with a minimum inhibitory concentration (MIC) of 0.125 mug/ml. Two months later, and after daptomycin therapy, the individual became bacteremic with an isolate of C. striatum with a daptomycin MIC of {\textgreater}256 mug/ml. To study the prevalence of daptomycin resistance in C. striatum, clinical isolates of C. striatum were grown in broth culture containing daptomycin to investigate the emergence of resistance to this antimicrobial. Molecular typing was used to evaluate serial isolates from the index patient and the clinical isolates of C. striatum we assayed. In vitro analysis of isolates from the index patient and 7 of 11 additional C. striatum isolates exhibited the emergence of high-level daptomycin resistance, despite initially demonstrating low MICs to this antimicrobial agent. This phenotype was persistent even after serial subculture in the absence of daptomycin. Together, these data demonstrate that caution should be taken when using daptomycin to treat high-inoculum infections and/or infections of indwelling medical devices with C. striatum. To our knowledge, this is the first report characterizing the emergence of daptomycin resistance in C. striatum.",E {McElvania TeKippe} and B S Thomas and G A Ewald and S J Lawrence and C A D Burnham,"1435-4373
0934-9723",Eur J Clin Microbiol Infect Dis,",Anti-Bacterial Agents/*pharmacology/therapeutic us,Bacteremia/drug therapy/microbiology,Bacterial,Corynebacterium Infections/drug therapy/*microbiol,Corynebacterium infection,Corynebacterium striatum,Corynebacterium/*drug effects/isolation {\&} purifica,Daptomycin/*pharmacology/therapeutic use,Drug Resistance,Heart-Assist Devices,Humans,Male,Microbial Sensitivity Tests,Middle Aged,Myocardial Ischemia/surgery,abscess drainage,adult,antibiotic resistance,article,bacteremia,bacterium culture,bacterium isolate,case report,cefalexin,ceftriaxone,ciprofloxacin,clindamycin,computer assisted tomography,daptomycin,debridement,drug fever,drug substitution,drug withdrawal,human,hypotension,implantable cardioverter defibrillator,in vitro study,in vivo study,ischemic cardiomyopathy,left ventricular assist device,linezolid,male,middle aged,minimum inhibitory concentration,molecular typing,nonhuman,phenotype,tetracycline,transthoracic echocardiography,vancomycin",2199--2205,{Rapid emergence of daptomycin resistance in clinical isolates of Corynebacterium striatum{\ldots} a cautionary tale},http://www.embase.com/search/results?subaction=viewrecord{\&}from=export{\&}id=L53216656 http://dx.doi.org/10.1007/s10096-014-2188-6 http://rd8hp6du2b.search.serialssolutions.com?sid=EMBASE{\&}issn=14354373{\&}id=doi:10.1007{\%}2Fs10096-014-2188-6{\&}atitle=Rapid+emergence,33,2014,12,"From Duplicate 2 (Rapid emergence of daptomycin resistance in clinical isolates of Corynebacterium striatum... a cautionary tale - McElvania TeKippe, E; Thomas, B S; Ewald, G A; Lawrence, S J; Burnham, C A)

1435-4373
McElvania TeKippe, E
Thomas, B S
Ewald, G A
Lawrence, S J
Burnham, C-A D
UL1 TR000448/TR/NCATS NIH HHS/United States
Case Reports
Journal Article
Germany
Eur J Clin Microbiol Infect Dis. 2014 Dec;33(12):2199-205. doi: 10.1007/s10096-014-2188-6. Epub 2014 Jun 28.",10.1007/s10096-014-2188-6,2014-06-29,eng,24973133,YES,Melanie,NO,Mushtaq,Zach,Zach_1,
12587,MAYBE,Lozano2011c,Article,"Objective: To study the clonal lineages, resistance mechanisms and virulence traits of tetracycline resistant (TetR) MRSA strains isolated in a Spanish Hospital during 2009. Methods: 34 TetR MRSA were detected from unrelated patients in Miguel Servet Hospital during 2009, representing 9.5{\%} of MRSA recovered in that period, and 27 of them were included in this study. The antibiotic susceptibility profile to 23 antibiotics was determined by Microscan{\textregistered} system. Presence of ermA, ermB, ermC, ermT, ermF, msrA/msrB, mphC, cfr, lsa(B), tetK, tetL, tetM, tetO, aac(6)aph(2), mupA, dfrA, dfrD, drfG, and dfrK genes was studied by PCR. Sequences of grlA and gyrA genes were analysed in some of the strains. Determination of SCCmec- and agr-typing was implemented on all MRSA isolates. Spa-typing was performed by PCR and sequencing. Presence of virulence factor genes lukF/lukS, tst, eta, etb, etd and cna was investigated by PCR. Results: The spa-types identified among the 27 TetR MRSA isolates were (no strains): t011 (12), t1197 (1), t3934 (2), t002 (1), t008 (1), t067 (3), t127 (2), t1381 (1), t2220 (2), and 2 new spa-types (t7613, t7577). Fifteen strains (55.6{\%}) were included in spa types related to the livestock-associated sequence type ST398 (t011, t1197 and t3934). These strains and one strain with a new spa-type (t7577) were typed as SCCmecV and agrI. The other strain with a new spa-type (t7613) presented a non-typable SCCmec and agrI. The remaining 10 MRSA strains were typed as SCCmecIV and agrI, agrII or agrIII. The following genes were detected (no strains): ermB (7), ermC (13), ermT (2), msrA/msrB (4), mphC (5), tetK (16), tetM (27), aac(6)aph(2) (5), dfrA (2) and mupA (3). Mutation in quinolone targets were studied in 10 ciprofloxacin resistant ST398 strains and all of them showed S80F amino acid change in GrlA, six also presented S84L, two S84A, one E84G and one no mutation in GyrA. Two strains were PVL positive (t7613 and t008) and 20 strains were cna positive. None of them presented tst, eta, etb and etd genes. Conclusion: More than half of TetR MRSA studied corresponded to spa types associated to the genetic lineage ST398. Tetracycline resistance could be a good initial marker to think about potential ST398, although this resistance can also be detected in other lineages. In addition, PVL positive MRSA were also detected in this collection.",C Lozano and A Rezusta and E G칩mez-Sanz and C Colmenarejo and R B치ez and D Benito and M Revillo and M Zarazaga and C Torres,1198-743X,Clinical Microbiology and Infection,"amino acid,antibiotic agent,antibiotic resistance,antibiotic sensitivity,ciprofloxacin,gene,hospital,human,livestock,marker,methicillin resistant Staphylococcus aureus,mutation,patient,quinolone,tetracycline,virulence,virulence factor",S204--S205,{Clonal lineages of tetracycline-resistant MRSA strains isolated in a Spanish hospital during 2009. Detection of MRSA ST398},http://www.embase.com/search/results?subaction=viewrecord{\&}from=export{\&}id=L70599517 http://dx.doi.org/10.1111/j.1469-0691.2011.03558.x http://rd8hp6du2b.search.serialssolutions.com?sid=EMBASE{\&}issn=1198743X{\&}id=doi:10.1111{\%}2Fj.1469-0691.2011.03558.x{\&}atitle=C,17,2011,NA,NA,NA,NA,NA,NA,MAYBE,Cale,MAYBE,Ayomide,Ayomide,Zach_1,
19685,MAYBE,Sonnevend2006,Article,"The antibiotic sensitivity and the serotype and molecular type (MT) distribution of 41 Campylobacter jejuni strains isolated from individual patients in Tawam Hospital, Al Ain, United Arab Emirates, were investigated. While all strains were sensitive to erythromycin (MIC 0.5-4 mg l(-1)), 35 isolates (85.4 {\%}) exhibited resistance to ciprofloxacin (MIC 8-64 mg l(-1)). All resistant strains carried the Thr-86 to Ile mutation in the gyrase A (gyrA) gene, as shown by mismatch amplification mutation assay (MAMA) and confirmed by sequencing. Based on the partial sequences of gyrA, resistant isolates carried 10 distinct alleles, eight of them representing new variants. Strains were assigned to 30 MTs based on the combined results of PFGE and flaA PCR-RFLP typing. Eight of the 35 ciprofloxacin-resistant strains, isolated over a period of more than 1 year, represented the largest MT, also carrying the same allelic variant of the gyrA gene. These results show that the local incidence of fluoroquinolone resistance among C. jejuni is one of the highest reported worldwide. It was also demonstrated that stable MTs could persist for a relatively long time among the clonally unrelated antibiotic-resistant isolates of C. jejuni. The data also emphasize the need to replace fluoroquinolones as empirical therapy for diarrhoea of undiagnosed aetiology.",A Sonnevend and V O Rotimi and J Kolodziejek and A Usmani and N Nowotny and T Pal,"0022-2615 (Print)
0022-2615",J Med Microbiol,"Anti-Infective Agents/*pharmacology,Base Sequence,Campylobacter Infections/microbiology,Campylobacter jejuni/*drug effects/genetics/isolat,Ciprofloxacin/*pharmacology,Cluster Analysis,DNA Gyrase/chemistry/genetics,DNA, Bacterial/chemistry/genetics,Diarrhea/microbiology,Drug Resistance, Bacterial,Electrophoresis, Gel, Pulsed-Field,Humans,Microbial Sensitivity Tests,Molecular Sequence Data,Point Mutation,Polymerase Chain Reaction,Polymorphism, Restriction Fragment Length,United Arab Emirates",1533--1538,{High level of ciprofloxacin resistance and its molecular background among Campylobacter jejuni strains isolated in the United Arab Emirates},NA,55,2006,Pt 11,"Sonnevend, Agnes
Rotimi, Vincent O
Kolodziejek, Jolanta
Usmani, Asad
Nowotny, Norbert
Pal, Tibor
Journal Article
Research Support, Non-U.S. Gov't
England
J Med Microbiol. 2006 Nov;55(Pt 11):1533-8.",10.1099/jmm.0.46744-0,2006-10-13,eng,17030913,MAYBE,Cale,MAYBE,Mushtaq,Mushtaq,Zach_1,
2989,YES,Camins2007,Article,"BACKGROUND: Vancomycin-resistant Enterococcus organisms (VRE) have emerged as common nosocomial pathogens, but few population-based data are available on the impact of invasive VRE infections. METHODS: We assessed the incidence of invasive VRE infections and predictors of mortality among patients identified during prospective, population-based surveillance performed in the metropolitan statistical area (MSA) of Atlanta, Georgia. RESULTS: From July 1997 through June 2000, a total of 192 patients who resided in the Atlanta MSA developed an invasive VRE infection, for a rate of 1.57 cases per 100,000 person-years. The incidence of invasive VRE disease significantly increased from 0.91 cases per 100,000 person-years during the first year of the study to 1.73 cases per 100,000 person-years during the third year of the study (P{\textless}.001). Rates of invasive VRE infection were significantly higher among African American patients than white patients (2.59 vs 0.70 cases per 100,000 person-years; P{\textless}.001). Blood was the most common sterile site from which VRE was recovered (161 [83{\%}] of 193 isolates), followed by deep surgical sites (17 [9{\%}]), peritoneal fluid (10 [5{\%}]), pleural fluid (3 [2{\%}]), and cerebrospinal fluid (1 [0.5{\%}]). In multivariate analysis, a Charlson comorbidity index of 5 or greater, previous receipt of antibiotic therapy, having 2 or more sets of blood cultures positive for VRE, and receipt of central parenteral nutrition were independent predictors of mortality, whereas receipt of an antibiotic with in vitro activity against the VRE isolate was associated with a decreased risk of mortality. Molecular typing revealed 38 different pulsed-field gel electrophoresis patterns, but the 2 most common pulsed-field gel electrophoresis types were found at 3 Emory University-affiliated hospitals. CONCLUSIONS: The incidence of invasive VRE infection significantly increased in the Atlanta MSA during the 3-year study period, with significant racial disparities detected. Receipt of an antimicrobial agent with in vitro activity against VRE was associated with a lower mortality rate. Molecular typing results demonstrated polyclonal emergence of VRE in Atlanta.",B C Camins and M M Farley and J J Jernigan and S M Ray and J P Steinberg and H M Blumberg,"0899-823X (Print)
0899-823x",Infect Control Hosp Epidemiol,"*Enterococcus/drug effects/pathogenicity,*Vancomycin Resistance,Adult,African Americans,Aged,Cross Infection/*mortality,European Continental Ancestry Group,Female,Georgia/epidemiology,Gram-Positive Bacterial Infections/drug therapy/*m,Hospital Mortality,Humans,Incidence,Male,Middle Aged,Prognosis,Prospective Studies,Risk Factors,Sentinel Surveillance,Sex Factors",983--991,"{A population-based investigation of invasive vancomycin-resistant Enterococcus infection in metropolitan Atlanta, Georgia, and predictors of mortality}",NA,28,2007,8,"Camins, Bernard C
Farley, Monica M
Jernigan, John J
Ray, Susan M
Steinberg, James P
Blumberg, Henry M
Journal Article
Research Support, Non-U.S. Gov't
United States
Infect Control Hosp Epidemiol. 2007 Aug;28(8):983-91. Epub 2007 Jun 29.",10.1086/518971,2007-07-11,eng,17620248,MAYBE,Cale,YES,Ayomide,Ayomide,Zach_1,
1566,MAYBE,Barocci2015,Article,"This report describes a case of meningitis caused by Listeria monocytogenes in a stem cell transplant recipient on immunosuppressive therapy for cutaneous chronic graft-versus host disease. A 59-year-old woman had undergone allogeneic stem cell transplantation (from a matched unrelated donor) 13 months previously for chronic lymphocytic leukemia. She was on regular hematologic follow-up. Though her previous malignancy has been in remission, she was immunosuppressed due to the pharmacological treatment. We describe a meningitis caused by a typical food-borne pathogen, dangerous in patients with impaired cell-mediated immunity. Moreover the bacterium had a multidrug resistance, a rare characteristic in clinical listeriosis. Rapid diagnosis and treatment are key factors in these cases. We chose ampicillin and rifampicin that allowed a complete resolution of the clinical manifestations.",S Barocci and A Mancini and B Canovari and E Petrelli and E Sbriscia-Fioretti and A Licci and S D'Addesa and G Petrini and M Giacomini and A Renzi and A Migali and S Briscolini,"1121-7138 (Print)
1121-7138",New Microbiol,"Anti-Bacterial Agents/therapeutic use,Female,Hematopoietic Stem Cell Transplantation/*adverse e,Humans,Immunocompromised Host,Listeria monocytogenes/genetics/*isolation {\&} purif,Meningitis, Listeria/drug therapy/etiology/immunol,Middle Aged,Transplantation, Homologous/adverse effects",113--118,{Listeria monocytogenes meningitis in an immunocompromised patient},NA,38,2015,1,"Barocci, Simone
Mancini, Alessio
Canovari, Benedetta
Petrelli, Enzo
Sbriscia-Fioretti, Emanuela
Licci, Alberto
D'Addesa, Simona
Petrini, Giancarlo
Giacomini, Marinella
Renzi, Antonella
Migali, Antonio
Briscolini, Sara
Case Reports
Journal Article
Italy
New Microbiol. 2015 Jan;38(1):113-8. Epub 2015 Jan 1.",NA,2015-03-06,eng,25742155,MAYBE,Brooke,NO,Mushtaq,Allison,Zach_1,
20512,YES,Tang2016a,Article,"Spread of multidrug-resistant tuberculosis (MDR-TB) strains in the general population presents a serious threat to public health and severely threatens existing control efforts. Techniques such as spoligotyping and Mycobacterium interspersed repetitive units-variable-number tandem-repeat typing of mycobacterial isolates have been employed to confirm familial outbreaks of MDR-TB. We diagnosed and traced four MDR-TB cases in a family via genotyping. Despite aggressive treatment, the index case remained culture positive, but the other patients were cured. This is the first documentation of a familial MDR-TB outbreak affecting human immunodeficiency virus-seronegative patients in eastern Taiwan. Molecular techniques are important in the identification of sources of MDR-TB infections. The adult index case in our study developed MDR-TB due to poor compliance with the drug regimen (acquired resistance), followed by transmission of MDR-TB to his children in close household contact. This emphasizes the importance of an effective drug delivery program, such as directly observed treatment, to improve drug compliance and prevent the emergence of drug-resistant cases.",T Q Tang and S C Fu and Y H Chen and S T Chien and J J Lee and C B Lin,1016-3190,Tzu Chi Medical Journal,"Human immunodeficiency virus infected patient,Mycobacterium tuberculosis,Taiwan,adolescent,adult,aminosalicylic acid,antibiotic resistance,antibiotic sensitivity,article,case report,directly observed therapy,disease transmission,enzyme immunoassay,epidemic,ethambutol,female,genotype,human,indigenous people,isoniazid,kanamycin,male,moxifloxacin,multidrug resistant tuberculosis,patient compliance,protionamide,pyrazinamide,recurrent disease,rifabutin,rifampicin,sputum culture,sputum smear,streptomycin,thorax radiography,tuberculostatic agent",29--32,{Outbreak of multidrug-resistant tuberculosis in an aboriginal family in eastern Taiwan},http://www.embase.com/search/results?subaction=viewrecord{\&}from=export{\&}id=L600415540 http://dx.doi.org/10.1016/j.tcmj.2014.09.001 http://rd8hp6du2b.search.serialssolutions.com?sid=EMBASE{\&}issn=10163190{\&}id=doi:10.1016{\%}2Fj.tcmj.2014.09.001{\&}atitle=Outbreak+of+,28,2016,1,NA,NA,NA,NA,NA,MAYBE,Cale,YES,Nchedo,Nchedo,Zach_1,
17901,MAYBE,Rouli2012,Article,"Coxiella burnetii 109, with a 2.03-Mb genome, is a doxycycline-resistant human isolate that was isolated from the cardiac valve of a German male patient with Q fever endocarditis who died during the course of the treatment due to the bacterium's resistance to doxycycline. This new genome can be useful for future comparative genomic or Q fever studies.",L Rouli and J M Rolain and A {El Filali} and C Robert and D Raoult,"0021-9193
1098-5530",J Bacteriol,",*Genome,Anti-Bacterial Agents/therapeutic use,Bacterial,Bacterial/drug therapy/*microbiology,Bacterial/genetics,Coxiella burnetii,Coxiella burnetii/drug effects/*genetics/isolation,DNA,Doxycycline/*pharmacology,Drug Resistance,Endocarditis,Heart Valves/microbiology,Humans,Male,Molecular Sequence Data,Q Fever/*microbiology,Q fever,Sequence Analysis,antibiotic resistance,article,bacterial endocarditis,bacterial genome,bacterium isolation,comparative study,doxycycline,genetic analysis,heart valve,human,male,nonhuman,priority journal",6939,"{Genome sequence of Coxiella burnetii 109, a doxycycline-resistant clinical isolate}",http://www.embase.com/search/results?subaction=viewrecord{\&}from=export{\&}id=L366217859 http://dx.doi.org/10.1128/JB.01856-12 http://rd8hp6du2b.search.serialssolutions.com?sid=EMBASE{\&}issn=00219193{\&}id=doi:10.1128{\%}2FJB.01856-12{\&}atitle=Genome+sequence+of+Coxiell,194,2012,24,"From Duplicate 1 (Genome sequence of Coxiella burnetii 109, a doxycycline-resistant clinical isolate - Rouli, L; Rolain, J M; El Filali, A; Robert, C; Raoult, D)

1098-5530
Rouli, Laetitia
Rolain, Jean-Marc
El Filali, Adil
Robert, Catherine
Raoult, Didier
Journal Article
Research Support, Non-U.S. Gov't
United States
J Bacteriol. 2012 Dec;194(24):6939. doi: 10.1128/JB.01856-12.",10.1128/jb.01856-12,2012-12-05,eng,23209205,YES,Erica,NO,Mushtaq,Zach,Zach_1,
15012,MAYBE,Ngamskulrungroj2015,Article,"Clostridium difficile infection (CDI) is a leading cause of healthcare-associated morbidity and mortality worldwide. In Thailand, CDI exhibits low recurrence and mortality and its molecular epidemiology is unknown. CDI surveillance was conducted in a tertiary facility (Siriraj Hospital, Bangkok). A total of 53 toxigenic C. difficile strains from Thai patients were analyzed by multi-locus sequence typing (MLST), PCR ribotyping, and pulse-field gel electrophoresis (PFGE). The mean age of the cohort was 64 years and 62.3{\%} were female; 37.7{\%} of patients were exposed to {\textgreater} two antibiotics prior to a diagnosis of CDI, with beta-lactams the most commonly used drug (56.3{\%}). Metronidazole was used most commonly (77.5{\%}; success rate 83.9{\%}), and non-responders were treated with vancomycin (success rate 100{\%}). None of the isolates carried binary toxin genes. Most isolates (98.2-100{\%}) were susceptible to metronidazole, vancomycin, tigecycline and daptomycin. There were 11 sequence types (STs), 13 ribotypes (RTs) and four PFGE types. Six previously identified STs (ST12, ST13, ST14, ST33, ST41 and ST45) and five novel STs unique to Thailand (ST66, ST67, ST68, ST69 and ST70) were identified. PCR RTs UK 017 (ST45) (45.3{\%}) and UK 014/020 (ST33) (24.5{\%}) were the most common. High concordance was observed between the MLST and ribotyping results (p{\textless}0.001). C. difficile isolates from Thai patients were highly susceptible to standard antimicrobial agents. In conclusion, the five STs indicate the high genetic diversity and unique polymorphisms in Thailand. Moreover, the emergence of antimicrobial resistance to vancomycin warranted continuous surveillance to prevent further spread of the toxigenic C. difficile isolates.",P Ngamskulrungroj and S Sanmee and P Putsathit and P Piewngam and B Elliott and T V Riley and P Kiratisin and P Pusathit and P Piewngam and B Elliott and T V Riley and P Kiratisin,1932-6203,PLoS ONE,",Clostridium Infections/*epidemiology,Clostridium difficile infection,Clostridium difficile/*genetics/isolation {\&} purifi,Cross Infection/*epidemiology,Enterocolitis,Hospitals,Humans,Molecular Epidemiology,Molecular Sequence Data,Multilocus Sequence Typing,Pseudomembranous/epidemiology,Ribotyping,Teaching,Thailand,United Kingdom,antibiotic agent,antibiotic resistance,antiinfective agent,beta lactam,daptomycin,diagnosis,female,gene,genetic variability,health care,hospital,human,metronidazole,molecular epidemiology,morbidity,mortality,patient,pulsed field gel electrophoresis,ribotyping,teaching hospital,tigecycline,toxin,vancomycin",e0127026,{Molecular Epidemiology of Clostridium difficile Infection in a Large Teaching Hospital in Thailand},http://www.embase.com/search/results?subaction=viewrecord{\&}from=export{\&}id=L604666977 http://dx.doi.org/10.1371/journal.pone.0127026 http://rd8hp6du2b.search.serialssolutions.com?sid=EMBASE{\&}issn=19326203{\&}id=doi:10.1371{\%}2Fjournal.pone.0127026{\&}atitle=Molecula,10,2015,5,"From Duplicate 2 (Molecular Epidemiology of Clostridium difficile Infection in a Large Teaching Hospital in Thailand - Ngamskulrungroj, P; Sanmee, S; Putsathit, P; Piewngam, P; Elliott, B; Riley, T V; Kiratisin, P)

1932-6203
Ngamskulrungroj, Popchai
Sanmee, Sittinee
Putsathit, Papanin
Piewngam, Pipat
Elliott, Briony
Riley, Thomas V
Kiratisin, Pattarachai
Journal Article
Research Support, Non-U.S. Gov't
United States
PLoS One. 2015 May 22;10(5):e0127026. doi: 10.1371/journal.pone.0127026. eCollection 2015.",10.1371/journal.pone.0127026,2015-05-23,eng,26000789,MAYBE,Brooke,NO,Nchedo,Allison,Zach_1,
9573,MAYBE,Jankovic2011,Article,"We present a case of systemic Mycobacterium chelonae infection in an immunosuppressed patient with systemic lupus erythematosus (SLE), idiopathic hypoparathyroidism, and hypothyroidism. The patient was treated for 3 months for skin infection with clarithromycin monotherapy. Since her condition deteriorated, the antibiotic therapy was switched to intravenously administered clindamycin, cloxacillin, and meropenem. Due to further deterioration and isolation of M. chelonae from the blood culture, antimicrobial therapy was changed to azithromycin and amikacin. Drug-test sensitivity was performed, and the isolate was susceptible to clarithromycin only. The patient's deteriorating status prevented orally administered medication with clarithromycin (parenteral formulation is not registered in Croatia). The same antibiotic regime was continued until the isolation of Pseudomonas aeruginosa and Candida albicans. In addition, extensive calcifications in her brain were found on a computed tomography (CT) scan, which suggested Fahr's syndrome. Despite all measures and supportive care, the patient developed multiorgan failure and eventually died. There has been an increase in the number of infections by rapidly growing mycobacteria, but only a few cases of severe systemic infection with M. chelonae have been described. If the infection is diagnosed early and a patient is treated with appropriate drugs, dissemination can be avoided despite immunosuppression. For serious skin, bone, and soft-tissue disease, a minimum of 4 months of a combined drug therapy is necessary. This is the first report of M. chelonae infection in Croatia and the first-described M. chelonae infection in a patient with concomitant Fahr's syndrome. {\textcopyright} 2010 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases.",M Jankovic and L Zmak and V Krajinovic and K Viskovic and S {Sestan Crnek} and M Obrovac and V Haris and V {Katalinic Jankovic},1341-321X,Journal of Infection and Chemotherapy,"Candida albicans,Fahr disease,Mycobacterium chelonae,Pseudomonas aeruginosa,Pseudomonas infection,adult,amikacin,amphotericin B,antibiotic resistance,antibiotic sensitivity,article,artificial ventilation,azathioprine,azithromycin,brain calcification,candidiasis,case report,ciprofloxacin,clarithromycin,clindamycin,cloxacillin,computer assisted tomography,cotrimoxazole,deterioration,doxycycline,fatality,female,human,hypothyroidism,idiopathic hypoparathyroidism,imipenem,immune deficiency,linezolid,meropenem,methylprednisolone,minimum inhibitory concentration,multiple organ failure,mycobacteriosis,septic shock,skin biopsy,skin infection,subcutaneous nodule,systemic lupus erythematosus",264--267,{A fatal Mycobacterium chelonae infection in an immunosuppressed patient with systemic lupus erythematosus and concomitant Fahr's syndrome},http://www.embase.com/search/results?subaction=viewrecord{\&}from=export{\&}id=L51055591 http://dx.doi.org/10.1007/s10156-010-0110-4 http://rd8hp6du2b.search.serialssolutions.com?sid=EMBASE{\&}issn=1341321X{\&}id=doi:10.1007{\%}2Fs10156-010-0110-4{\&}atitle=A+fatal+Mycobac,17,2011,2,NA,NA,NA,NA,NA,YES,Jake,MAYBE,Allison,Allison,Zach_1,
6842,YES,Gales2006,Article,"We report the first linezolid-resistant Staphylococcus aureus strain isolated in Brazil. The strain was isolated from a 10-year-old female patient with cystic fibrosis (CF) who received repeated and prolonged courses of low-dose linezolid. The strain belonged to the Brazilian endemic methicillin-resistant S. aureus clone, and the G2576U mutation was identified in domain V of the 23S rRNA. Detection of this mechanism of resistance in a CF patient is very worrisome, as these patients may become a reservoir for further dissemination of resistant strains. Our findings emphasise the importance of optimal dosage of linezolid to prevent the emergence of resistance. {\textcopyright} 2006 Elsevier B.V. and the International Society of Chemotherapy.",A C Gales and H S Sader and S S Andrade and L Lutz and A Machado and A L Barth,0924-8579,Int J Antimicrob Agents,",23S/genetics,Acetamides/administration {\&} dosage/*pharmacology/t,Anti-Bacterial Agents/administration {\&} dosage/phar,Bacterial/*genetics,Brazil,Child,Cystic Fibrosis/*complications,Drug Resistance,Female,Humans,Linezolid,Methicillin Resistance,Oxazolidinones/administration {\&} dosage/*pharmacolo,Point Mutation,RNA,Ribosomal,Staphylococcal Infections/drug therapy/*microbiolo,Staphylococcus aureus,Staphylococcus aureus/*drug effects/isolation {\&} pu,Staphylococcus infection,antibiotic sensitivity,article,bacterial mutation,bacterial strain,bacterium isolate,case report,clinical examination,clinical feature,cystic fibrosis,dalfopristin plus quinupristin,female,human,linezolid,low drug dose,lung infection,methicillin resistant Staphylococcus aureus,molecular cloning,nonhuman,nucleotide sequence,priority journal,ribosome RNA,school child,treatment outcome,vancomycin",300--302,{Emergence of linezolid-resistant Staphylococcus aureus during treatment of pulmonary infection in a patient with cystic fibrosis},http://www.embase.com/search/results?subaction=viewrecord{\&}from=export{\&}id=L43606664 http://dx.doi.org/10.1016/j.ijantimicag.2005.11.008 http://rd8hp6du2b.search.serialssolutions.com?sid=EMBASE{\&}issn=09248579{\&}id=doi:10.1016{\%}2Fj.ijantimicag.2005.11.008{\&}atitle,27,2006,4,"From Duplicate 1 (Emergence of linezolid-resistant Staphylococcus aureus during treatment of pulmonary infection in a patient with cystic fibrosis - Gales, A C; Sader, H S; Andrade, S S; Lutz, L; Machado, A; Barth, A L)

Gales, Ana C
Sader, Helio S
Andrade, Soraya S
Lutz, Larissa
Machado, Adao
Barth, Afonso L
Case Reports
Journal Article
Netherlands
Int J Antimicrob Agents. 2006 Apr;27(4):300-2. Epub 2006 Mar 9.",10.1016/j.ijantimicag.2005.11.008,2006-03-11,eng,16527459,YES,Cale,YES,Ayomide,Ayomide,Zach_1,
4581,MAYBE,Dalal2008c,Article,"The French word enterocque was first used in 1899 by Thiercelin to describe gram-positive cocci of enteric origin that formed pairs and short chains. The genus Enterococcus includes 17 species. Most human clinical infections are caused by either Enterococcus faecalis (74{\%}-90{\%}) or Enterococcus faecium (5{\%}-16{\%}). Since its identification in 1989, Enterococcus raffinosus has been rarely associated with human infections. We describe a case of vancomycin-resistant E. raffinosus native valve infective endocarditis. E. raffinosus was isolated from the patient's blood cultures. The patient was treated with ampicillin for 6 weeks and gentamicin for the first 2 weeks with complete recovery. {\textcopyright} 2008 Lippincott Williams {\&} Wilkins, Inc.",A Dalal and C Urban and D Rubin and M Ahluwalia,1056-9103,Infectious Diseases in Clinical Practice,"Enterococcus raffinosus,aged,ampicillin,antibiotic therapy,bacterial endocarditis,bacterium culture,bacterium isolation,blood culture,case report,daptomycin,drug withdrawal,enterococcal infection,female,gentamicin,human,linezolid,moxifloxacin,penicillin G,review,treatment duration,treatment outcome,vancomycin,vancomycin resistant Enterococcus",144--146,{Vancomycin-resistant Enterococcus raffinosus endocarditis: A case report and review of literature},http://www.embase.com/search/results?subaction=viewrecord{\&}from=export{\&}id=L351775669 http://dx.doi.org/10.1097/IPC.0b013e31816379fc http://rd8hp6du2b.search.serialssolutions.com?sid=EMBASE{\&}issn=10569103{\&}id=doi:10.1097{\%}2FIPC.0b013e31816379fc{\&}atitle=Vancomyc,16,2008,3,NA,NA,NA,NA,NA,MAYBE,Cale,MAYBE,Brooke,Brooke,Zach_1,
3195,YES,Carvalho2006,Article,"Metallo-beta-lactamase production is emerging worldwide as an important mechanism of carbapenem resistance among nonfermentative Gram-negative isolates, and this mechanism is becoming frequently observed in Brazil. This study documents the occurrence and characteristics of an epidemic SPM-1-producing Pseudomonas aeruginosa strain in a teaching hospital located in Rio de Janeiro City, Brazil. The bla (SPM-1) gene and a class 1 integron were detected in 13 isolates, representing 20{\%} of the 65 imipenem-resistant P. aeruginosa isolates obtained from January, 2000, to August, 2001. DNA sequencing revealed that this integron carries three gene cassettes that confer resistance to antimicrobials, aacA4, bla (OXA-56), and aadA7, and an orf1 encoding a putative transposase. All 13 SPM-producing P. aeruginosa isolates had closely related pulsed-field gel electrophoresis (PFGE) profiles, designated as clonal group A, suggesting nosocomial spread of the strain. This clonal group was the same as that observed in other SPM-1-producing P. aeruginosa isolates from distinct Brazilian states. The dissemination of this clone throughout Brazil could not be explained by transfer of infected patients and/or sharing of common health-care staff. It is likely that the spread of these strains occurred indirectly via the community.",A P Carvalho and R M Albano and D N {de Oliveira} and D A Cidade and L M Teixeira and A {Marques Ede},"1076-6294 (Print)
1076-6294",Microb Drug Resist,"Anti-Bacterial Agents/*pharmacology,Base Sequence,Brazil/epidemiology,Carbapenems/*pharmacology,Colony Count, Microbial,Disease Outbreaks,Drug Resistance, Multiple, Bacterial/*genetics,Electrophoresis, Gel, Pulsed-Field,Genes, Bacterial,Hospitals, Teaching,Humans,Integrons,Microbial Sensitivity Tests,Molecular Sequence Data,Pseudomonas Infections/epidemiology/*microbiology,Pseudomonas aeruginosa/*drug effects/enzymology/is,beta-Lactamases/*genetics",103--108,"{Characterization of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-beta-lactamase in a hospital located in Rio de Janeiro, Brazil}",NA,12,2006,2,"Carvalho, Ana Paula D'Alincourt
Albano, Rodolpho Mattos
de Oliveira, Denise Neves
Cidade, Daniela Anhel de Paula
Teixeira, Lucia Martins
Marques, Elizabeth de Andrade
Journal Article
Research Support, Non-U.S. Gov't
United States
Microb Drug Resist. 2006 Summer;12(2):103-8.",10.1089/mdr.2006.12.103,2006-08-23,eng,16922625,MAYBE,Brooke,NO,Erica,Allison,Zach_1,
496,YES,Alexander2011,Article,"OBJECTIVE: To retrospectively review trends in clindamycin resistance among Staphylococcus aureus head and neck abscesses between January 2000 and June 2008. METHODS: Between January 2000 and June 2008, inpatient and outpatient S aureus isolates were reviewed for antibiotic susceptibility. In particular, cultures from 153 abscesses in the head and neck region were assessed for clindamycin and methicillin resistance patterns. RESULTS: Annual clindamycin resistance rates for all S aureus isolates, and specifically for S aureus head and neck abscesses, revealed concerning levels of clindamycin and methicillin resistance. After 2002, the mean clindamycin resistance rate in head and neck abscesses was approximately 27{\%}. The number of new cases of methicillinresistant S aureus per year increased from four cases in 2000 to 44 cases in 2007. CONCLUSION: Antibiotic resistance should be considered following failed empirical therapy of head and neck abscesses with clindamycin. {\textcopyright}2011 Pulsus Group Inc. All rights reserved.",A J Alexander and S E Richardson and A Sharma and P Campisi,1712-9532,Canadian Journal of Infectious Diseases and Medical Microbiology,"Staphylococcus aureus,Staphylococcus infection,abscess,adolescent,antibiotic resistance,antibiotic sensitivity,article,bacterium culture,bacterium isolate,child,childhood disease,clindamycin,head and neck abscess,head and neck infection,hospital patient,human,infant,major clinical study,methicillin resistant Staphylococcus aureus,methicillin resistant Staphylococcus aureus infect,meticillin,outpatient,penicillin resistance,preschool child,retrospective study,school child,trend study",49--51,{The increasing prevalence of clindamycin resistance in Staphylococcus aureus isolates in children with head and neck abscesses},http://www.embase.com/search/results?subaction=viewrecord{\&}from=export{\&}id=L362073682 http://rd8hp6du2b.search.serialssolutions.com?sid=EMBASE{\&}issn=17129532{\&}id=doi:{\&}atitle=The+increasing+prevalence+of+clindamycin+resistance+in+Staphylococcus+aureus+isolates,22,2011,2,NA,NA,NA,NA,NA,MAYBE,Brooke,YES,Nchedo,Nchedo,Zach_1,
1102,YES,Aspiroz2010a,Article,NA,C Aspiroz and I Martin and C Lozano and C Torres,0213-005x,Enferm Infecc Microbiol Clin,"Adrenal Cortex Hormones/therapeutic use,Adult,Analgesics/therapeutic use,Anti-Bacterial Agents/administration {\&} dosage/ther,Back Pain/drug therapy/etiology,Bacteremia/drug therapy/*microbiology,Bacterial Toxins/*analysis,Ceftriaxone/administration {\&} dosage/therapeutic us,Dominican Republic/ethnology,Drug Therapy, Combination,Emergencies,Exotoxins/*analysis,Headache/drug therapy/etiology,Humans,Leukocidins/*analysis,Male,Meningitis, Bacterial/drug therapy/*microbiology,Methicillin-Resistant Staphylococcus aureus/chemis,Spain/epidemiology,Staphylococcal Infections/drug therapy/*microbiolo,Vancomycin/administration {\&} dosage/therapeutic use",70--71,{[First case of community-acquired Panton-Valentine leukocidin-positive (ST88) methicillin-resistant Staphylococcus aureus bacteriemia in Spain in a patient with meningitis]},NA,28,2010,1,"1578-1852
Aspiroz, Carmen
Martin, Isabel
Lozano, Carmen
Torres, Carmen
Case Reports
Letter
Spain
Enferm Infecc Microbiol Clin. 2010 Jan;28(1):70-1. doi: 10.1016/j.eimc.2009.01.016. Epub 2009 May 1.",10.1016/j.eimc.2009.01.016,2009-05-05,spa,19409675,YES,Allison,YES,Ayomide,Ayomide,Zach_1,
9937,MAYBE,Kaase2011,Article,"Objectives: To analyse the mechanisms responsible for carbapenem resistance in one Acinetobacter baumannii isolate recovered from a patient transferred to Germany from an Egyptian hospital. Methods: PCR and sequencing were used to search for $\beta$-lactamase and 16S RNA methylase genes. Multilocus sequence typing was used to determine the sequence type (ST) of the isolate. Results: Sequencing of the PCR product obtained using primers for blaNDM-1 revealed a variant of NDM-1 that had a C to G substitution at position 82 resulting in an amino acid substitution of proline to alanine at position 28. This variant was designated NDM-2. Genes encoding extended-spectrum $\beta$-lactamases or 16S RNA methylase were not detected. The strain lacked detectable plasmids and blaNDM-2 was not transferred by conjugation. MLST showed that the isolate belonged to a new ST, ST103. Conclusions: This work further underlines the spread of NDM carbapenemases in A. baumannii, and the spread of the corresponding gene in the Middle East. It also describes the first variant of NDM-1. {\textcopyright} The Author 2011. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved.",M Kaase and P Nordmann and T A Wichelhaus and S G Gatermann and R A Bonnin and L Poirel,"0305-7453
1460-2091",Journal of Antimicrobial Chemotherapy,"Acinetobacter baumannii,Acinetobacter infection,DNA extraction,Egypt,NDM 2 carbapenemase,RNA 16S,RNA methyltransferase,Staphylococcus epidermidis,alanine,amikacin,amino acid substitution,antibiotic resistance,antibiotic sensitivity,article,bacterial enzyme,bacterial strain,bacterium culture,bacterium isolate,brain edema,case report,cefepime,ceftazidime,central venous catheter,child,clinical assessment,colistin,doripenem,extended spectrum beta lactamase,fatality,gene amplification,gene expression,gene sequence,genetic variability,gentamicin,hospitalization,human,imipenem,intensive care unit,meropenem,minimum inhibitory concentration,molecular cloning,multidrug resistance,multilocus sequence typing,pelvis fracture,plasmid,plasmid DNA,polymerase chain reaction,prognosis,proline,rifampicin,spleen injury,splenic laceration,tigecycline,tobramycin,traumatic brain injury,unclassified drug",1260--1262,{NDM-2 carbapenemase in Acinetobacter baumannii from Egypt},http://www.embase.com/search/results?subaction=viewrecord{\&}from=export{\&}id=L361771074 http://dx.doi.org/10.1093/jac/dkr135 http://rd8hp6du2b.search.serialssolutions.com?sid=EMBASE{\&}issn=03057453{\&}id=doi:10.1093{\%}2Fjac{\%}2Fdkr135{\&}atitle=NDM-2+carbapenemase+in+Aci,66,2011,6,NA,NA,NA,NA,NA,YES,Brooke,NO,Nchedo,Allison,Zach_1,
22926,MAYBE,Yan2014a,Article,"Seven imipenem-resistant Pseudomonas aeruginosa isolates were recovered from the sputum samples of pneumonia patients in southwestern China. They had identical antibiotic resistance patterns and indistinguishable pulsed-field gel electrophoresis profiles. Nucleotide sequence analysis revealed a 4-bp (AGTC) insertion in the oprD gene, resulting in a frameshift in the cognate open reading frame. These isolates became imipenem susceptible when the chromosomal oprD lesion was complemented, indicating that the 4-bp insertion in the oprD gene resulted in imipenem resistance.",Y Yan and X Yao and H Li and Z Zhou and W Huang and C W Stratton and C D Lu and Y W Tang,0095-1137,J Clin Microbiol,"*Disease Outbreaks,*Frameshift Mutation,Adult,Aged,Aged, 80 and over,Anti-Bacterial Agents/pharmacology,China/epidemiology,DNA, Bacterial/chemistry/genetics,Electrophoresis, Gel, Pulsed-Field,Genetic Complementation Test,Genotype,Humans,Imipenem/pharmacology,Intensive Care Units,Male,Microbial Sensitivity Tests,Molecular Sequence Data,Molecular Typing,Mutagenesis, Insertional,Pneumonia, Bacterial/epidemiology/*microbiology,Porins/*genetics,Pseudomonas Infections/epidemiology/*microbiology,Pseudomonas aeruginosa/drug effects/*genetics/isol,Sequence Analysis, DNA,Sputum/microbiology",4388--4390,{A novel Pseudomonas aeruginosa strain with an oprD mutation in relation to a nosocomial respiratory infection outbreak in an intensive care unit},NA,52,2014,12,"1098-660x
Yan, Yingjun
Yao, Xiangyu
Li, Haijing
Zhou, Zhonghua
Huang, Wenfang
Stratton, Charles W
Lu, Chung-Dar
Tang, Yi-Wei
Journal Article
United States
J Clin Microbiol. 2014 Dec;52(12):4388-90. doi: 10.1128/JCM.02782-14. Epub 2014 Oct 8.",10.1128/jcm.02782-14,2014-10-10,eng,25297323,YES,Erica,MAYBE,Zach,Zach,Zach_1,
1451,YES,Banerjee2013b,Article,NA,T Banerjee and S Anupurba,0255-0857,Indian J Med Microbiol,"Administration, Intravenous,Adult,Anti-Bacterial Agents/*metabolism/*therapeutic use,Bacterial Proteins/genetics,Carbon-Oxygen Ligases/genetics,DNA, Bacterial/genetics,Enterococcus/drug effects/*growth {\&} development/is,Feces/*microbiology,Female,Humans,India,Microbial Sensitivity Tests,Polymerase Chain Reaction,Vancomycin Resistance,Vancomycin/*metabolism/*therapeutic use,purification/*metabolism",91--92,{Isolation and characterization of the first vancomycin-dependent Enterococcus from India},NA,31,2013,1,"1998-3646
Banerjee, T
Anupurba, S
Case Reports
Letter
India
Indian J Med Microbiol. 2013 Jan-Mar;31(1):91-2. doi: 10.4103/0255-0857.108747.",10.4103/0255-0857.108747,2013-03-20,eng,23508442,YES,Allison,YES,Erica,Erica,Zach_1,
20553,YES,Tarazona2007,Article,NA,R E R Tarazona and T P Padilla and J C Gomez and J E Sanchez and M S Hernandez and J C S G칩mez and J E G S치nchez and M S Hernandez,"0924-8579 (Print)
0924-8579",Int J Antimicrob Agents,",Acetamides/*pharmacology,Adult,Anti-Bacterial Agents/*pharmacology,Bacterial,DNA fragment,Drug Resistance,Gunshot/drug therapy,Humans,Linezolid,Male,Microbial Sensitivity Tests,Oxazolidinones/*pharmacology,RNA gene,Spain,Staphylococcal Infections/*microbiology,Staphylococcus haemolyticus,Staphylococcus haemolyticus/*drug effects,Staphylococcus simulans,Wound Infection/drug therapy/microbiology,Wounds,adult,amoxicillin plus clavulanic acid,ampicillin,antibiotic resistance,bacterial gene,bacterial strain,bacterium isolate,case report,cefazolin,cefotaxime,chloramphenicol,clindamycin,cotrimoxazole,dalfopristin plus quinupristin,drug mechanism,erythromycin,gene mutation,genotype,gentamicin,gunshot injury,human,intravenous catheter,letter,linezolid,male,meropenem,metronidazole,minimum inhibitory concentration,nonhuman,oxacillin,penicillin G,piperacillin plus tazobactam,priority journal,ribosome RNA,rifampicin,teicoplanin,thorax injury,vancomycin,wound infection",277--278,{First report in Spain of linezolid non-susceptibility in a clinical isolate of Staphylococcus haemolyticus},http://www.embase.com/search/results?subaction=viewrecord{\&}from=export{\&}id=L47126814 http://dx.doi.org/10.1016/j.ijantimicag.2007.04.010 http://rd8hp6du2b.search.serialssolutions.com?sid=EMBASE{\&}issn=09248579{\&}id=doi:10.1016{\%}2Fj.ijantimicag.2007.04.010{\&}atitle,30,2007,3,"From Duplicate 2 (First report in Spain of linezolid non-susceptibility in a clinical isolate of Staphylococcus haemolyticus - Tarazona, R E; Padilla, T P; Gomez, J C; Sanchez, J E; Hernandez, M S)

Tarazona, Raquel Elisa Rodriguez
Padilla, Trinidad Parras
Gomez, Juan Carlos Sanchez
Sanchez, Jose Elias Garcia
Hernandez, Manuel Sanchez
Case Reports
Letter
Netherlands
Int J Antimicrob Agents. 2007 Sep;30(3):277-8. Epub 2007 Jun 27.",10.1016/j.ijantimicag.2007.04.010,2007-06-30,eng,17600688,YES,Allison,YES,Ayomide,Ayomide,Zach_1,
23251,MAYBE,Zago2016,Article,NA,M C B Zago and G F Viana and A B S Ecker and S A B Nishiyama and M N Zarpellon and J R C Dias and C L Cardoso and M C B Tognim,"1532-2939
0195-6701",Journal of Hospital Infection,"Acinetobacter baumannii,Acinetobacter infection,Brazil,amplicon,antibiotic resistance,bacterial gene,bacterium culture,bacterium detection,bacterium isolate,beta lactamase CTX M,beta lactamase CTX M 15,blaCTX M 15 gene,blaCTX M gene,blaOXA 23 gene,blaOXA 51 gene,case report,cefepime,ceftazidime,ceftriaxone,enzyme synthesis,genotype,heterozygote,human,imipenem,letter,meropenem,multiplex polymerase chain reaction,nonhuman,nucleotide sequence,polymyxin B,sequence analysis,unclassified drug",298--299,{First report of CTX-M-15-producing Acinetobacter baumannii in Brazil},http://www.embase.com/search/results?subaction=viewrecord{\&}from=export{\&}id=L607895524 http://dx.doi.org/10.1016/j.jhin.2015.11.016 http://rd8hp6du2b.search.serialssolutions.com?sid=EMBASE{\&}issn=15322939{\&}id=doi:10.1016{\%}2Fj.jhin.2015.11.016{\&}atitle=First+report,92,2016,3,NA,NA,NA,NA,NA,MAYBE,Cale,MAYBE,Mushtaq,Mushtaq,Zach_1,
23593,MAYBE,Zimhony2006,Article,"Three episodes of bacteremia occurred in the course of prosthetic valve endocarditis caused by an extended-spectrum-beta-lactamase (ESBL)-producing Klebsiella pneumoniae strain. The second isolate developed resistance to ciprofloxacin and the third isolate to piperacillin-tazobactam (PIP-TZ) following sequential therapy with each agent. The first isolate was resistant to PIP-TZ only at high inocula, the second isolate acquired increased transcription of the acrA gene, and the third isolate became resistant to PIP-TZ due to loss of beta-lactamase inhibition by TZ. We question if and how PIP-TZ susceptibility should be reported for ESBL-producing Enterobacteriaceae.",O Zimhony and I Chmelnitsky and R Bardenstein and S Goland and O H Muntz and S N Venezia and Y Carmeli and O {Hammer Muntz} and S {Navon Venezia} and Y Carmeli,"0066-4804 (Print)
0066-4804",Antimicrob Agents Chemother,",*Drug Resistance,Bacterial,Bacterial/*drug therapy/microbiology,Ciprofloxacin/pharmacology/*therapeutic use,Endocarditis,Female,Heart Valve Prosthesis/microbiology,Humans,Klebsiella Infections/*drug therapy/microbiology,Klebsiella pneumoniae,Klebsiella pneumoniae/*drug effects/enzymology/gen,Middle Aged,Multiple,Penicillanic Acid/analogs {\&} derivatives/pharmacolo,Piperacillin/pharmacology/therapeutic use,Prosthesis-Related Infections/drug therapy/microbi,Thienamycins/therapeutic use,adult,amikacin,antibiotic resistance,article,bacterial endocarditis,beta lactamase,beta-Lactamases/*biosynthesis/metabolism,case report,cefepime,cefoxitin,ciprofloxacin,female,human,meropenem,minimum inhibitory concentration,mitral valve prosthesis,nalidixic acid,nucleotide sequence,piperacillin plus tazobactam,polymerase chain reaction,postoperative complication,priority journal,prosthesis infection",3179--3182,{Endocarditis caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: emergence of resistance to ciprofloxacin and piperacillin-tazobactam during treatment despite initial susceptibility},http://www.embase.com/search/results?subaction=viewrecord{\&}from=export{\&}id=L44396433 http://dx.doi.org/10.1128/AAC.00218-06 http://rd8hp6du2b.search.serialssolutions.com?sid=EMBASE{\&}issn=00664804{\&}id=doi:10.1128{\%}2FAAC.00218-06{\&}atitle=Endocarditis+caused+by+ex,50,2006,9,"From Duplicate 1 (Endocarditis caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: emergence of resistance to ciprofloxacin and piperacillin-tazobactam during treatment despite initial susceptibility - Zimhony, O; Chmelnitsky, I; Bardenstein, R; Goland, S; Hammer Muntz, O; Navon Venezia, S; Carmeli, Y)

Zimhony, Oren
Chmelnitsky, Inna
Bardenstein, Rita
Goland, Sorel
Hammer Muntz, Orly
Navon Venezia, Shiri
Carmeli, Yehuda
Case Reports
Journal Article
United States
Antimicrob Agents Chemother. 2006 Sep;50(9):3179-82.",10.1128/aac.00218-06,2006-08-31,eng,16940124,YES,Jake,MAYBE,Brooke,Brooke,Zach_1,
20841,YES,Tijet2011a,Article,NA,N Tijet and D C Alexander and D Richardson and O Lastovetska and D E Low and S N Patel and R G Melano,1080-6040,Emerg Infect Dis,"Adult,Anti-Bacterial Agents/pharmacology,Canada,Carbapenems/pharmacology,Female,Humans,India,Klebsiella Infections/*diagnosis/epidemiology/*mic,Klebsiella pneumoniae/classification/*drug effects,Microbial Sensitivity Tests,Ontario,Travel,Urinary Tract Infections/*diagnosis/epidemiology/m,beta-Lactam Resistance,beta-Lactamases/*biosynthesis/genetics",306--307,"{New Delhi metallo-beta-lactamase, Ontario, Canada}",NA,17,2011,2,"1080-6059
Tijet, Nathalie
Alexander, David C
Richardson, David
Lastovetska, Olga
Low, Donald E
Patel, Samir N
Melano, Roberto G
Case Reports
Letter
United States
Emerg Infect Dis. 2011 Feb;17(2):306-7. doi: 10.3201/eid1702.101561.",10.3201/eid1702.101561,2011-02-05,eng,21291614,NO,Brooke,YES,Erica,Zach,Zach_1,
